Manoj Khadka: Omega-3s and Cardiovascular Outcomes in Hemodialysis
Manoj Khadka, Resident Doctor at Patan Hospital, shared a post on LinkedIn, about recent article by Charmaine E. Lok et al., published in NEJM, adding:
“Pleased to share my journal abstract presentation reviewing the PISCES trial, published in NEJM (Nov 2025), which evaluated the impact of omega-3 fatty acid (fish oil) supplementation on cardiovascular events in patients undergoing maintenance hemodialysis.
The presentation focused on the study methodology, key findings, clinical implications, and future directions regarding the role of fish oil in cardiovascular risk reduction among dialysis patients.”
Title: Fish Oil Supplementation Reduces Cardiovascular Events in Hemodialysis Patient
Authors: Charmaine E. Lok, M.D., Michael Farkouh, M.D., Brenda R. Hemmelgarn, M.D., Ph.D., Louise M. Moist, M.D., Kevan R. Polkinghorne, M.B., Ch.B., Ph.D., George Tomlinson, Ph.D., Paul Tam, M.D., Marcello Tonelli, M.D. and Jacob A. Udell, M.D., M.P.H.
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 22, 2026, 09:18Shamee Shastry: How Transfusion Medicine Research Is Evolving in India
-
Sep 22, 2026, 09:11Tarique Shahzad Chachar: Why Warfarin Remains the Gold Standard for Mechanical Heart Valves
-
Sep 22, 2026, 09:04Bianca Rocca: Thromboinflammatory Injury in Ischemic Limb Necrosis During Severe Shock
-
Sep 22, 2026, 09:01Ash Paul: Comparing Left Atrial Appendage Occlusion and Oral Anticoagulation
-
Sep 22, 2026, 08:50Emily Horner: Lipoprotein(a) Links Oxidized Phospholipids to Platelet Hyperactivity
-
Sep 22, 2026, 08:42Sally Mandour: Bone Marrow Needle Gauge Explained
-
Sep 22, 2026, 08:39Alessandro Sionis: Navigating Anticoagulation in Mechanical Circulatory Support
-
Sep 22, 2026, 08:28Raghavendra Rao: The Latest Research on Varicose Veins
-
Sep 22, 2026, 08:23Aravind Palraj: Three Essential Tests in Antiphospholipid Syndrome